文献速递胃肠外科

抗血栓治疗是结直肠手术吻合口漏的风险因素:前瞻性队列研究

Antithrombotic Therapy Is a Risk Factor for Anastomotic Leakage in Prospective Cohort of Colorectal Surgery Patients.
PubMed 文献 · J Am Coll Surg · 2026-06-12

该研究为前瞻性多中心队列的二次分析,纳入2家教学医院1346例结直肠手术患者,采用LASSO法筛选术前风险因素后行多因素logistic回归。118例(8.8%)发生吻合口漏,抗血栓治疗(OR 2.10,95%CI 1.27-3.44)、既往结直肠手术(OR 1.69,95%CI 1.04-2.70)、男性(OR 1.99,95%CI 1.30-3.10)及吻合口距肛缘小于5 cm(OR 2.28,95%CI 1.15-5.67)为独立风险因素。

要点

  • 抗血栓治疗是结直肠手术吻合口漏的独立风险因素(OR 2.10)。
  • 男性、既往结直肠手术、低位吻合(距肛缘<5 cm)亦为风险因素。
  • 术前应综合评估抗血栓治疗等风险以优化患者选择。

核心结论

  • 抗血栓治疗是结直肠手术后吻合口漏的独立风险因素,此外男性、既往结直肠手术和吻合口靠近肛缘也是已知风险因素。

研究设计与样本

  • 前瞻性多中心队列的二次分析,纳入2家教学医院1346例结直肠手术患者。
  • 吻合口漏定义为术后30天内影像学或手术证实吻合口裂开,或吻合口附近引流脓液或肠内容物。
  • 术前风险因素基于临床推理选择,采用LASSO法分析后行多因素logistic回归。

主要发现

  • 1346例中118例(8.8%)发生吻合口漏。
  • 抗血栓治疗OR 2.10(95%CI 1.27-3.44)。
  • 既往结直肠手术OR 1.69(95%CI 1.04-2.70)。
  • 男性OR 1.99(95%CI 1.30-3.10)。
  • 吻合口距肛缘小于5 cm OR 2.28(95%CI 1.15-5.67)。

临床怎么用

  • 术前应评估抗血栓治疗、既往结直肠手术史、性别及吻合口位置等风险因素,以优化患者选择并降低吻合口漏发生率。

局限性

  • 原文未报告局限性内容。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Anastomotic leakage is a serious and potentially lethal complication after colorectal surgery. Careful patient selection is essential to reduce its incidence. This study aimed to identify preoperative risk factors for anastomotic leakage using a large, multicenter cohort. STUDY DESIGN: In this secondary analysis of a prospective multicenter cohort, 1,346 patients undergoing colorectal surgery in 2 teaching hospitals were included. Anastomotic leakage was defined as radiological or surgical confirmation of anastomotic dehiscence, or drainage of pus or enteral content near the anastomosis within 30 days postoperatively. Preoperative risk factors were selected based on clinical reasoning and analyzed using the Least Absolute Shrinkage and Selection Operator method, followed by multivariable logistic regression. RESULTS: Of the 1,346 patients, 118 (8.8%) developed anastomotic leakage. Identified risk factors included antithrombotic therapy (odds ratio [OR] 2.10, 95% CI 1.27-3.44), previous colorectal surgery (OR 1.69, 95% CI 1.04-2.70), male sex (OR 1.99, 95% CI 1.30-3.10), and anastomosis less than 5 cm from the anal verge (OR 2.28, 95% CI 1.15-5.67). CONCLUSIONS: Antithrombotic therapy emerged as an independent risk factor for anastomotic leakage after colorectal surgery, in addition to known risk factors as male sex, previous colorectal surgery, and an anastomosis close to the anal verge. Further research is warranted to clarify this association.

来源:J Am Coll Surg,查看原文。版权归原作者所有。

引用

  1. Cats M, Plate JD, Genders C, et al. Antithrombotic Therapy Is a Risk Factor for Anastomotic Leakage in Prospective Cohort of Colorectal Surgery Patients. J Am Coll Surg. 2026. PMID: 41733254. doi:10.1097/XCS.0000000000001885

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。